iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021)

iSpecimen (ISPC) posted quarterly Preferred Stock Liabilities of $561041.0 for Q1 2021, down 94.98% on a QoQ basis from $11.2 million in Q4 2020.

iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

iSpecimen (ISPC) has reported Preferred Stock Liabilities for 2 consecutive years, with $561041.0 the latest figure, recorded in Q1 2021.

In Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $561041.0; the TTM figure through Mar 2021 stood at $561041.0 (changed N/A YoY), while the FY2020 annual figure was $11.2 million, changed N/A from the prior year.
Preferred Stock Liabilities came in at $561041.0 for Q1 2021 at iSpecimen, down from $11.2 million in the prior quarter.
The five-year high for Preferred Stock Liabilities was $11.2 million in Q4 2020, with the low at $561041.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	-
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	-
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	-
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	-
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	-
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	-
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	-
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	-
10	iSpecimen	931,959.22	-1.89 Mn	-1.39 Mn	-

Download Data